Welcome to Davipharm
the one you trust
Domestic manufacturer with European standards
Davipharm – the one you trust
*Source: IQVIA, MATQ12020
Vietnam’s First HP Zone
On 16 April 2021, Davipharm announced the certification of Vietnam’s first High Potency (HP) Drugs Zone for the production of cytotoxic/cytostatic oral solids. These are oncological drugs in hard shell capsules, tablets, and coated tablets. According to new regulations from Vietnam’s Ministry of Health, as well as guidelines from the World Health Organization (WHO), European Medicines Agency (EMA) and Pharmaceutical Inspection Co-operation Scheme (PIC/S), the production of certain products containing hazardous substances must be run at separate premises meeting specific criteria.
Davipharm’s portfolio includes 28 high potency (HP) drugs, among them oncology drugs for treatment of breast cancer, leukemia, pancreas, colorectal, stomach, cervix, prostate and lung cancer and glioblastoma.
We have the capacity to produce batches from 15kg to 100kg with an annual output of 500 million units of HP drugs.The total capacity of the factory is 1,8 billion units a year.